Patent · US Active

Immunoglobulin variable domains

US11220539B2 · kind B2 · utility

5Cited by
9References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 9, 2020
Grant dateJan 11, 2022
Priority date
Expiry dateDec 9, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/31
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

VH domain, in which: (i) the amino acid residue at position 112 is one of K or Q; and/or (ii) the amino acid residue at position 89 is T; and/or (iii) the amino acid residue at position 89 is L and the amino acid residue at position 110 is one of K or Q; and (iv) in each of cases (i) to (iii), the amino acid at position 11 is preferably V; and in which said VH domain contains a C-terminal extension (X)n, in which n is 1 to 10, preferably 1 to 5, such as 1, 2, 3, 4 or 5 (and preferably 1 or 2, such as 1); and each X is an (preferably naturally occurring) amino acid residue that is independently chosen, and preferably independently chosen from the group consisting of alanine (A), glycine (G), valine (V), leucine (L) or isoleucine (I).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.